Importantly, T-ALL cells treated with these selective kinase blockers displayed reduced levels of ZAP70 and STAT5 activation without significantly altering their total protein levels (Supplemental Figure 11E). This evidence concerns the gene ZAP70 and acute lymphoblastic leukemia.